Bio-Techne Corporation
General ticker "TECH" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $9.2B (TTM average)
Bio-Techne Corporation follows the US Stock Market performance with the rate: 32.9%.
Estimated limits based on current volatility of 0.1%: low 72.16$, high 72.36$
Factors to consider:
- Company included in S&P500 list
- Company pays dividends (quarterly): last record date 2026-08-24, amount 0.08$ (Y0.44%)
- Total employees count: 3000 (-3.2%) as of 2026
- US accounted for 56.7% of revenue in the fiscal year ended 2024-06-30
- Top business risk factors: Geopolitical risks, Supply chain disruptions, Raw material price increases, Labor/talent shortage/retention, Market competition
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2026-06-30 to 2028-06-29
- 2026-06-30 to 2027-06-30 estimated range: [44.90$, 69.16$]
- 2027-06-30 to 2028-06-29 estimated range: [48.50$, 73.51$]
Financial Metrics affecting the TECH estimates:
- Positive: with PPE of 33.6 at the end of fiscal year the price was neutral
- Positive: 15.80 < Operating profit margin, % of 20.73
- Positive: 2.37 < Operating cash flow per share per price, % of 2.89
- Negative: negative Industry operating cash flow (median)
- Positive: Inventory ratio change, % of 0.22 <= 0.41
- Negative: Industry earnings per price (median), % of -16.07 <= 0
- Positive: Industry inventory ratio change (median), % of 0 <= 0
Short-term TECH quotes
Long-term TECH plot with estimates
Financial data
| YTD | 2024-06-30 | 2025-06-30 | 2026-06-30 |
|---|---|---|---|
| Operating Revenue | $1,159.06MM | $1,219.63MM | $1,215.04MM |
| Operating Expenses | $952.37MM | $1,117.38MM | $963.15MM |
| Operating Income | $206.69MM | $102.25MM | $251.89MM |
| Non-Operating Income | $-21.00MM | $-3.79MM | $-11.21MM |
| Interest Expense | $15.74MM | $8.51MM | $5.41MM |
| R&D Expense | $96.66MM | $99.50MM | $94.77MM |
| Income(Loss) | $185.69MM | $98.46MM | $240.68MM |
| Taxes | $17.58MM | $25.06MM | $58.82MM |
| Net Income(Loss)* | $168.10MM | $73.40MM | $181.86MM |
| Stockholders Equity | $2,068.85MM | $1,918.81MM | $2,108.22MM |
| Inventory | $179.73MM | $189.45MM | $195.74MM |
| Assets | $2,703.87MM | $2,557.87MM | $2,678.99MM |
| Operating Cash Flow | $298.98MM | $287.56MM | $292.07MM |
| Capital expenditure | $62.88MM | $31.01MM | $28.85MM |
| Investing Cash Flow | $-203.03MM | $-35.18MM | $-18.19MM |
| Financing Cash Flow | $-122.40MM | $-253.91MM | $-169.11MM |
| Earnings Per Share** | $1.07 | $0.47 | $1.17 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.